SCACP

SCACP
  • 文章类型: Systematic Review
    视神经囊腺癌乳头瘤(SCACP)是一种罕见且侵袭性的恶性附件肿瘤,起源于大汗腺或多能附件腺,通常与先前的乳头瘤(SCAP)或色斑痣(NS)有关。本系统综述通过对1980年至2024年间记录的78例病例的分析,严格检查了SCACP。该研究旨在提供对临床表现的全面审查,诊断,治疗方式,以及与SCACP相关的结果,在重新评估其协会的同时,特别是NS。SCACP主要影响老年人,平均年龄为66.3岁,男性占主导地位,通常表现为头皮上的溃疡结节或斑块。这篇综述强调了SCACP的侵略性,显著的转移和复发率证明了这一点。治疗主要是手术,Mohs显微手术在切缘控制和美容效果方面提供了潜在的好处。对SCACP与NS的关联进行了严格评估,提示复杂的病因,并强调认识到这种关联对于及时诊断和治疗的重要性。我们的评论还简要讨论了临床医生在SCACP诊断中面临的潜在陷阱。我们的发现强调了标准化治疗方案和进一步研究靶向治疗以改善SCACP患者预后的必要性。
    Syringocystadenocarcinoma papilliferum (SCACP) is a rare and aggressive malignant adnexal tumor originating from apocrine or pluripotent appendageal glands, often associated with a preceding syringocystadenoma papilliferum (SCAP) or nevus sebaceus (NS). This systematic review rigorously examines SCACP through an analysis of 78 cases documented between 1980 and 2024. The study aims to provide a comprehensive review of the clinical manifestations, diagnosis, treatment modalities, and outcomes associated with SCACP, while also reappraising its associations, particularly with NS. SCACP predominantly affects older adults, with an average age of 66.3 years and a slight male predominance, commonly presenting as ulcerated nodules or plaques on the scalp. This review highlights the aggressive nature of SCACP, evidenced by significant rates of metastasis and recurrence. Treatment is primarily surgical, with Mohs micrographic surgery offering potential benefits in terms of margin control and cosmetic outcomes. The association of SCACP with NS is critically evaluated, suggesting a complex etiopathogenesis and underscoring the importance of recognizing this association for timely diagnosis and management. Our review also briefly discusses potential pitfalls faced by clinicians in the diagnosis of SCACP. Our findings emphasize the need for standardized treatment protocols and further research into targeted therapies to improve patient outcomes in SCACP.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    外耳道恶性肿瘤(EAC)占所有头颈部癌症的0.2%以下。EAC癌的发病率估计为每百万人口中的六分之一。EAC的大多数癌症是鳞状细胞癌和基底细胞癌。一些罕见和不寻常的肿瘤确实发生在耳道内,包括恶性黑色素瘤。默克尔细胞癌,血管肉瘤,淋巴瘤和附件癌,如宫颈腺癌和腺样囊性癌。宫颈腺肿瘤约占所有外耳道肿瘤的5%。除非肿瘤表现为从外耳道突出的基底肿块,否则外耳道癌很难诊断。视神经囊腺癌(SCACP)是一种极为罕见的皮肤附件肿瘤。视神经囊腺瘤(SCAP)被认为是SCACP的前体。在全身的文献中已经报道了大约50例SCACP。诊断困难,切除活检成为诊断和治疗的必要条件。我们介绍了一名中年女性外耳道SCACP病例。据我们所知和信仰,这是英文文献中第一例外耳道SCACP。这促使我们报告这个案子。
    Malignant tumors of external auditory canal (EAC) constitute less than 0.2% of all head and neck cancers. The incidence of carcinoma of the EAC is estimated to be between one in six per million populations. Majority of cancers of EAC are squamous cell carcinomas and basal cell carcinomas. Some rare and unusual tumors do occur within the ear canal including malignant melanoma, merkel cell carcinoma, angiosarcoma, lymphoma and adnexal carcinomas like ceruminous adenocaricinoma and adenoid cystic carcinoma. Ceruminous glands tumors constitute about 5% of all external auditory canal tumors. Carcinoma of the external auditory canal is a difficult diagnosis unless the tumors presents as a fungating mass protruding from the external auditory canal. Syringocystadenocarcinoma Papilliferum (SCACP) is an extremely rare cutaneous adnexal neoplasm. Syringocystadenoma papilliferum (SCAP) is thought to be precursor of SCACP. About 50 cases of SCACP have been reported in literature all over the body. The diagnosis is difficult and excisional biopsy becomes mandatory for diagnosis and treatment. We present a case of SCACP in the external auditory canal in a middle-aged female. To the best of our knowledge and belief, this is the first case of SCACP in the external auditory canal in the English literature. This prompted us to report this case.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Sci-hub)

       PDF(Pubmed)

公众号